Characteristics of equine mesenchymal stem cells derived from amnion and bone marrow: <i>In vitro</i> proliferative and multilineage potential assessment

Abstract

The amniotic membrane could be a valuable source of MSCs to be used both for allogenic and/or autologous therapies. The noninvasive nature and low cost of collection, the rapid proliferation along with a greater differentiation potential and the 'off the shelf' preparation potential could make AMCs useful for cell therapy.